Annual D&A
$122.00 K
-$926.00 K-88.36%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual depreciation & amortization is $122.00 thousand, with the most recent change of -$926.00 thousand (-88.36%) on December 31, 2023.
- During the last 3 years, AMPE annual D&A has fallen by -$1.05 million (-89.63%).
- AMPE annual D&A is now -90.48% below its all-time high of $1.28 million, reached on December 31, 2018.
Performance
AMPE Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$0.00
$0.000.00%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly depreciation & amortization is $0.00, unchanged on December 31, 2023.
- Over the past year, AMPE quarterly D&A has dropped by -$183.00 thousand (-100.00%).
- AMPE quarterly D&A is now -100.00% below its all-time high of $371.00 thousand, reached on June 30, 2019.
Performance
AMPE Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$122.00 K
-$183.00 K-60.00%
December 31, 2023
Summary
- As of February 8, 2025, AMPE TTM depreciation & amortization is $122.00 thousand, with the most recent change of -$183.00 thousand (-60.00%) on December 31, 2023.
- Over the past year, AMPE TTM D&A has dropped by -$926.00 thousand (-88.36%).
- AMPE TTM D&A is now -91.26% below its all-time high of $1.40 million, reached on June 30, 2019.
Performance
AMPE TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
AMPE Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -88.4% | -100.0% | -88.4% |
| 3 y3 years | -89.6% | -100.0% | -89.6% |
| 5 y5 years | -90.5% | -100.0% | -90.4% |
AMPE Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -88.8% | at low | -100.0% | at low | -89.2% | at low |
| 5 y | 5-year | -90.4% | at low | -100.0% | at low | -90.4% | at low |
| alltime | all time | -90.5% | -100.0% | -100.0% | at low | -91.3% | +682.0% |
Ampio Pharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $122.00 K(-88.4%) | $0.00(0.0%) | $122.00 K(-60.0%) |
| Sep 2023 | - | $0.00(0.0%) | $305.00 K(-53.2%) |
| Jun 2023 | - | $0.00(-100.0%) | $652.00 K(-28.2%) |
| Mar 2023 | - | $122.00 K(-33.3%) | $908.00 K(-13.4%) |
| Dec 2022 | $1.05 M(-4.2%) | $183.00 K(-47.3%) | $1.05 M(-7.1%) |
| Sep 2022 | - | $347.00 K(+35.5%) | $1.13 M(+8.0%) |
| Jun 2022 | - | $256.00 K(-2.3%) | $1.04 M(-1.7%) |
| Mar 2022 | - | $262.00 K(-0.4%) | $1.06 M(-2.9%) |
| Dec 2021 | $1.09 M(-7.1%) | $263.00 K(0.0%) | $1.09 M(-2.6%) |
| Sep 2021 | - | $263.00 K(-4.0%) | $1.12 M(-2.7%) |
| Jun 2021 | - | $274.00 K(-6.8%) | $1.15 M(-1.9%) |
| Mar 2021 | - | $294.00 K(+0.7%) | $1.18 M(-0.1%) |
| Dec 2020 | $1.18 M(-7.5%) | $292.00 K(-0.7%) | $1.18 M(-0.4%) |
| Sep 2020 | - | $294.00 K(-0.7%) | $1.18 M(+4.9%) |
| Jun 2020 | - | $296.00 K(+0.3%) | $1.13 M(-6.2%) |
| Mar 2020 | - | $295.00 K(-0.7%) | $1.20 M(-5.5%) |
| Dec 2019 | $1.27 M(-0.7%) | $297.00 K(+24.3%) | $1.27 M(-1.2%) |
| Sep 2019 | - | $239.00 K(-35.6%) | $1.29 M(-7.7%) |
| Jun 2019 | - | $371.00 K(+1.6%) | $1.40 M(+3.8%) |
| Mar 2019 | - | $365.00 K(+16.6%) | $1.35 M(+5.0%) |
| Dec 2018 | $1.28 M(+5.5%) | $313.00 K(-9.7%) | $1.28 M(+0.7%) |
| Sep 2018 | - | $346.80 K(+8.3%) | $1.27 M(+3.5%) |
| Jun 2018 | - | $320.30 K(+6.4%) | $1.23 M(+1.4%) |
| Mar 2018 | - | $300.90 K(-0.9%) | $1.21 M(-0.2%) |
| Dec 2017 | $1.21 M | $303.70 K(+0.0%) | $1.21 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $303.60 K(-0.0%) | $1.21 M(-0.2%) |
| Jun 2017 | - | $303.70 K(+0.1%) | $1.21 M(-0.1%) |
| Mar 2017 | - | $303.50 K(+1.9%) | $1.21 M(-0.2%) |
| Dec 2016 | $1.21 M(+47.2%) | $297.90 K(-2.5%) | $1.21 M(+8.1%) |
| Sep 2016 | - | $305.50 K(0.0%) | $1.12 M(+9.8%) |
| Jun 2016 | - | $305.50 K(0.0%) | $1.02 M(+10.8%) |
| Mar 2016 | - | $305.50 K(+47.8%) | $923.90 K(+12.0%) |
| Dec 2015 | $824.80 K(+142.0%) | $206.70 K(+0.5%) | $824.80 K(+10.1%) |
| Sep 2015 | - | $205.70 K(-0.1%) | $749.00 K(+11.8%) |
| Jun 2015 | - | $206.00 K(-0.2%) | $670.10 K(+32.4%) |
| Mar 2015 | - | $206.40 K(+57.7%) | $506.00 K(+48.5%) |
| Dec 2014 | $340.80 K(+147.5%) | $130.90 K(+3.2%) | $340.80 K(+36.2%) |
| Sep 2014 | - | $126.80 K(+202.6%) | $250.30 K(+53.5%) |
| Jun 2014 | - | $41.90 K(+1.7%) | $163.10 K(+1.6%) |
| Mar 2014 | - | $41.20 K(+2.0%) | $160.50 K(+16.5%) |
| Dec 2013 | $137.70 K(+120.7%) | $40.40 K(+2.0%) | $137.80 K(+21.9%) |
| Sep 2013 | - | $39.60 K(+0.8%) | $113.00 K(+27.0%) |
| Jun 2013 | - | $39.30 K(+112.4%) | $89.00 K(+36.3%) |
| Mar 2013 | - | $18.50 K(+18.6%) | $65.30 K(+4.6%) |
| Dec 2012 | $62.40 K(+46.5%) | $15.60 K(0.0%) | $62.40 K(+33.3%) |
| Sep 2012 | - | $15.60 K(0.0%) | $46.80 K(+50.0%) |
| Jun 2012 | - | $15.60 K(0.0%) | $31.20 K(+100.0%) |
| Mar 2012 | - | $15.60 K | $15.60 K |
| Dec 2011 | $42.60 K(>+9900.0%) | - | - |
| Dec 2010 | $0.00 | - | - |
FAQ
- What is Ampio Pharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual D&A year-on-year change?
- What is Ampio Pharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly D&A year-on-year change?
- What is Ampio Pharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals TTM D&A year-on-year change?
What is Ampio Pharmaceuticals annual depreciation & amortization?
The current annual D&A of AMPE is $122.00 K
What is the all time high annual D&A for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual depreciation & amortization is $1.28 M
What is Ampio Pharmaceuticals annual D&A year-on-year change?
Over the past year, AMPE annual depreciation & amortization has changed by -$926.00 K (-88.36%)
What is Ampio Pharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of AMPE is $0.00
What is the all time high quarterly D&A for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly depreciation & amortization is $371.00 K
What is Ampio Pharmaceuticals quarterly D&A year-on-year change?
Over the past year, AMPE quarterly depreciation & amortization has changed by -$183.00 K (-100.00%)
What is Ampio Pharmaceuticals TTM depreciation & amortization?
The current TTM D&A of AMPE is $122.00 K
What is the all time high TTM D&A for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high TTM depreciation & amortization is $1.40 M
What is Ampio Pharmaceuticals TTM D&A year-on-year change?
Over the past year, AMPE TTM depreciation & amortization has changed by -$926.00 K (-88.36%)